Insilico Sees Rising Revenue From Deals With AI Firms
Alex Zhavoronkov, Founder & CEO at Insilico Medicine, discusses the AI-drug discovery firm's earnings and business outlook exclusively on "Bloomberg: The China Show." (Source: Bloomberg)
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.